Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Vaccine 0.5 mL Injection
RxNorm 2705460

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2705460 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Vaccine 0.5 mL Injection.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
0.5 mL Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 mg/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 mg/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 mg/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 mg/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 mg/ML Injection
Primary clinical definition
AUI:12949387
View
PSN
Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Vaccine 0.5 mL Injection
AUI:12949404
View
SY
Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 mcg / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 mcg / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 mcg / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 mcg / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 mcg / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 mcg / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 mcg / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 mcg per 0.5 mL Injection
AUI:12949398
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
0.5 mL Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 mg/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 mg/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 mg/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 mg/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 mg/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 mg/ML Injection
(Atom ID: 12949387)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2705460
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12949387
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2705460
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1601398} 1601231
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1601399} 1601233
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1601400} 1601236
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2705454} 1601232
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{901506} 901505
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{901508} 901507
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{901510} 901509
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{901512} 901511
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1601398} 1593128
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1601399} 1593128
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1601400} 1593128
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2705454} 1593128
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{901506} 901505
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{901508} 901507
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{901510} 901509
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{901512} 901511
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.02 MG/ML / 0.1 MG/ML (expressed as Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen) / 0.1 MG/ML (expressed as Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen) / 0.1 MG/ML (expressed as Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen) / 0.05 MG/ML (expressed as Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle) / 0.01 MG/ML / 0.01 MG/ML / 0.01 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1601398} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1601399} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1601400} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2705454} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{901506} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{901508} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{901510} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{901512} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN QUANTITY
0.5 ML
Normal Form quantity factor
PSNPrescribable

Prescribable Name (PSN):
Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Vaccine 0.5 mL Injection
(Atom ID: 12949404)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Vaccine 0.5 ML Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2705460
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12949404
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2705460
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 mcg / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 mcg / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 mcg / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 mcg / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 mcg / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 mcg / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 mcg / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 mcg per 0.5 mL Injection
(Atom ID: 12949398)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG per 0.5 ML Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2705460
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12949398
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2705460
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.